Equibles does not estimate personal net worth.
Get an email with a short summary when Relmada Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RLMD alertsBipin Dalmia has spoken on 1 earnings call across 1 company, most recently for Relmada Therapeutics, Inc. on November 12, 2026. Relmada Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relmada Therapeutics, Inc. includes Sergio Traversa (CEO and Board Member), Charles J. Casamento (Chairman and Board Member), Maged Shenouda (CFO) and 4 others.
“For bladder-sparing therapies in non-muscle-invasive bladder cancer, or NMIBC, patients and physicians are still forced to trade off efficacy, durability, tolerability, and convenience.”
Transcript header (unverified)
Biotechnology · Healthcare
